nach oben

Erschienen in:

01.05.2014 | Review

Negative affect in systemic sclerosis

verfasst von: Leticia Leon, Lydia Abasolo, Marta Redondo, Miguel Angel Perez-Nieto, Luis Rodriguez-Rodriguez, Maria Isabel Casado, Rafael Curbelo, Juan Ángel Jover

Erschienen in: Rheumatology International | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Negative affect appears frequently in rheumatic diseases, but studies about their importance and prevalence in systemic sclerosis patients are scarce, and the results are inconclusive separately. We conducted a comprehensive search on April 2013 of PubMed, Medline, and PsycINFO databases to identify original research studies published. A total of 48 studies were included in this systematic review. We found negative emotions have very high levels in these patients, compared to both healthy population other chronic rheumatic patients assessed with the same instruments and cutoffs. Depression has been, of the three negative emotions that we approach to in this review, the most widely studied in systemic sclerosis, followed by anxiety. Despite the fact that anger is a common emotion in these diseases is poorly studied. Methodologic issues limited the ability to draw strong conclusions from studies of predictors. Disease-specific symptoms (swollen joints, gastrointestinal and respiratory symptoms and digital ulcers) and factors related to physical appearance were associated with negative emotions. Interdisciplinary care and biopsychosocial approach would have a great benefit in the clinical management of these patients.

Wilson IB, Cleary PD (1995) Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. J Am Med Assoc 273:59–65CrossRef

Consedine NS, Magai C, Cohen CI, Gilespie M (2002) Ethnic variation in the impact of negative affect and emotion inhibition on the health of older adults. J Gerontol Ser B Psychol Sci 57B:396–408CrossRef

Schulz R, Drayer RA, Rollman BL (2002) Depression as a risk factor for non-suicide mortality in the elderly. Biol Psychiatry 52:205–225PubMedCrossRef

Suls J, Bunde J (2005) Anger, anxiety and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psychol Bull 131:260–300PubMedCrossRef

Ang DC, Choi H, Kroenke K, Wolfe F (2005) Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 32:1013–1019PubMed

Cuijpers P, Smit H (2002) Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 72:227–236PubMedCrossRef

Rosemann T, Laux G, Kuehlein T (2007) Osteoarthritis and functional disability: results of a cross sectional study among primary care patients in Germany. BMC Musculoskelet Disord 8:79PubMedCentralPubMedCrossRef

Joyce AT, Smith P, Khandker R, Melin JM, Singh A (2009) Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. J Rheumatol 36:743–752PubMedCrossRef

Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef

10.

Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62PubMedCentralPubMedCrossRef

11.

Thombs BD, Fuss S, Hudson M, Schieir O, Taillefer SS, Fogel J, Ford DE, Baron M, Canadian Scleroderma Research Group (2008) High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. Arthritis Rheum 59(3):431–437PubMedCrossRef

12.

Thombs BD, Hudson M, Schieir O, Taillefer SS, Baron M, Canadian Scleroderma Research Group (2008) Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis. Arthritis Rheum 59(3):438–443PubMedCrossRef

13.

Kwakkenbos L, Arthurs E, van den Hoogen FH, Hudson M, van Lankveld WG, Baron M, van den Ende CH, Thombs BD, Canadian Scleroderma Research Group (2013) Cross-language measurement equivalence of the Center for Epidemiologic Studies Depression (CES-D) scale in systemic sclerosis: a comparison of Canadian and Dutch patients. PLoS One 8(1):e53923. doi:10.1371/journal.pone.0053923 PubMedCentralPubMedCrossRef

14.

Thombs BD, Hudson M, Bassel M, Taillefer SS, Baron M, Canadian Scleroderma Research Group (2009) Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis Rheum 61(7):966–973. doi:10.1002/art.24614 PubMedCrossRef

15.

Milette K, Hudson M, Baron M, Thombs BD, Canadian Scleroderma Research Group (2010) Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates. Rheumatology (Oxford) 49(4):789–796CrossRef

16.

Arthurs E, Steele RJ, Hudson M, Baron M, Thombs BD, (CSRG) Canadian Scleroderma Research Group (2012) Are scores on English and French versions of the PHQ-9 comparable? An assessment of differential item functioning. PLoS One 7(12):e52028. doi:10.1371/journal.pone.0052028 PubMedCentralPubMedCrossRef

17.

Beck A, Ward C, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedCrossRef

18.

Beck A (1972) Screening depressed patients in family practice: a rapid technique. Postgrad Med 56:81–85

19.

Montgomery SA, Asberg M (1979) A new scale designed to be sensitive to change. Br J Psychiatry 134:382–389PubMedCrossRef

20.

Zung WW (1965) A self-rating depression scale. Arch Gen Psychiatry 12:63–70PubMedCrossRef

21.

Bedford A, Fould GA (1978) Delusions-symptoms-states Inventory States of Anxiety and Depression (Manual). NFER Publishing, Windsor

22.

Derogatis LR, Covi L, Lipman RS (1973) The SCL-90: an out-patients psychiatric rating scale. Psychopharmacol Bull 9:13–28PubMed

23.

Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D (2002) The revised Illness Perception Questionnaire (IPQ-R). Psychol Health 17:1–16CrossRef

24.

Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE (1992) AIMS2: the content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum 35:1–10PubMedCrossRef

25.

Derogatis LR (1986) The Psychosocial Adjustment to Illness Scale (PAIS). J Psychosom Res 30:77–91PubMedCrossRef

26.

Hudson M, Thombs BD, Steele R, Watterson R, Taillefer S, Baron M, Canadian Scleroderma Research Group Investigators (2008) Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II. Arthritis Rheum 59(2):279–284. doi:10.1002/art.23344 PubMedCrossRef

27.

Leavens A, Patten SB, Hudson M, Baron M, Thombs BD, Canadian Scleroderma Research Group (CSRG) (2012) Influence of somatic symptoms on PHQ-9 depression scores among patients with systemic sclerosis compared to a healthy general population sample. Arthritis Care Res (Hoboken). doi:10.1002/acr.21675

28.

Roca RP, Wigley FM, White B (1996) Depressive symptoms associated with scleroderma. Arthritis Rheum 29(6):1035–1040

29.

Benrud-Larson LM, Haythornwaite JA, Heinberg LJ, Boling C, Reed J, White B, Wigley FM (2002) The impact of pain and symptoms of depression in scleroderma. Pain 95:267–275PubMedCrossRef

30.

Matsuura E, Ohta A, Kanegae F, Haruda Y, Ushiyama O, Koarada S, Togashi R, Tada Y, Suzuki N, Nagasawa K (2003) Frecuency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma. J Rheumatol 30(8):1782–1787PubMed

31.

Richards HL, Herrick AL, Griffin K, Gwilliam PDH, Loukes J, Fortune DG (2003) Systemic sclerosis: patient’s perceptions of their condition. Arthritis Care Res 49(5):689–696CrossRef

32.

Benrud-Larson LM, Heinberg LJ, Boling C, Reed J, White B, Wigley FM, Haythornwaite JA (2003) Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function. Health Psychol 22(2):130–139PubMedCrossRef

33.

Vera-Lastra O, Martinez R, Pacheco M, Medina G, Jara LJ, Ariza R (2006) Frecuency of depressive symptoms in systemic sclerosis (SSC) and treatment with flouxetine. J Clin Rheumatol 12(4 Suppl):S83CrossRef

34.

Thombs BD, Hudson M, Taillefer SS, Baron M, Canadian Scleroderma Research Group (2008) Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis Rheum 59(4):504–509. doi:10.1002/art.23524 PubMedCrossRef

35.

Legendre C, Allanore Y, Ferrand I, Kahan A (2005) Evaluation of depression and anxiety in patients with systemic sclerosis. Joint Bone Spine 72:408–411PubMedCrossRef

36.

Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Tilley BC, Silver RM (2005) Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol 32(1):51–57PubMed

37.

Taillefer SS, Baron M, Hudson M (2005) Predictors of depressive symptoms in patients with systemic sclerosis (SSC). Ann Rheum Dis 64:925

38.

Taillefer S, Baron M, Hudson M (2005) Disability, pain and dyspnea predict levels of depression in systemic sclerosis (SSC). Arthritis Rheum 52(9 S):1569

39.

Khanna D, Ahmed M, Furst DE, Ginsburg SS, Park GS, Hornung R, Tsevat J (2007) Health values of patients with systemic sclerosis. Arthritis Rheum 57(1):86–93PubMedCrossRef

40.

Bodukam V, Hays RD, Maranian P, Furst DE, Seibold JR, Impens A, Mayes MD, Clements PJ, Khanna D (2011) Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis. Rheumatology 50:330–334PubMedCentralPubMedCrossRef

41.

Ostojic P, Zivojinovic S, Reza T, Damjanov N (2010) Symptoms of depression and anxiety in Serbian patients with systemic sclerosis: impact of disease severity and socioeconomic factors. Mod Rheumatol 20(4):353–357PubMedCrossRef

42.

Mozzetta A, Antinone V, Alfani S, Neri P, Bonda PGF, Pasquini P, Puddu P, Picardi A (2008) Mental health in patients with systemic sclerosis: a controlled investigation. J Eur Acad Dermatol Venereol 22(3):336–340PubMedCrossRef

43.

Baubet T, Ranque B, Taïeb O, Bérezné A, Bricou O, Mehallel S, Moroni C, Belin C, Pagnoux C, Moro MR, Guillevin L, Mouthon L (2011) Mood and anxiety disorders in systemic sclerosis patients. Presse Med 40(2):e111–e119PubMedCrossRef

44.

Angelopoulos NV, Drosos AA, Moutsopoulos HM (2001) Psychiatric symptoms associated with scleroderma. Psychother Psychosom 70:145–150PubMedCrossRef

45.

Jewett LR, Razykov I, Hudson M, Baron M, Thombs BD, Canadian Scleroderma Research Group (2013) Prevalence of current, 12-month and lifetime major depressive disorder among patients with systemic sclerosis. Rheumatology (Oxford) 52(4):669–675. doi:10.1093/rheumatology/kes347 CrossRef

46.

Wafki F, Amine B, Ibn Yacoub Y, Laatiriss A, Znat F, Abouqal R, Hajjaj-Hassouni N (2012) Depression among the Moroccan systemic sclerosis. Clin Rheumatol 31(1):73–77PubMedCrossRef

47.

Walker JG, Steele RJ, Schnitzer M, Taillefer S, Baron M, Canadian Scleroderma Research Group, Hudson M (2010) The association between disease activity and duration in systemic sclerosis. J Rheumatol 37(11):2299–2306PubMedCrossRef

48.

Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsger TA, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jiménez SA, White B, Seibold JR, Wigley FM, For the Scleroderma Cinical Trials Consortium (2002) Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon. Arthritis Rheum 46(9):2410–2420PubMedCrossRef

49.

Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Silver RM (2004) How do functional status and gastrointestinal dysfunction influence depression among patients with systemic sclerosis? Arthritis Rheum 50(9):S1174

50.

Hyphantis TN, Tsifetaki N, Pappa C, Voulgari PV, Siafaka V, Bai M, Alamanos Y, Drosos AA, Mavreas V (2007) Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. J Psycosom Res 62(1):47–56CrossRef

51.

Frech T, Hays RD, Maranian P, Clements PJ, Furst DE, Khanna D (2011) Prevalence and correlates of sleep disturbance in systemic sclerosis—results from the UCLA scleroderma quality of life study. Rheumatology (Oxford) 50(7):1280–1287CrossRef

52.

Sariyildiz MA, Batmaz I, Budulgan M, Bozkurt M, Yazmalar L, Inanir A, Celepkolu T, Cevik R (2013) Sleep quality in patients with systemic sclerosis: relationship between the clinical variables, depressive symptoms, functional status, and the quality of life. Rheumatol Int (Epub ahead of print)

53.

54.

Lawrence JW, Heinberg LJ, Roca R, Munster A, Spence R, Fauerbach JA (1998) Development and validation of the Satisfaction with Appearance Scale: assessing body image among burn-injured patients. Psychol Assess 10:64–70CrossRef

55.

Kwakkenbos L, van Lankveld WG, Vonk MC, Becker ES, van den Hoogen FH, van den Ende CH (2012) Disease-related and psychosocial factors associated with depressive symptoms in patients with systemic sclerosis, including fear of progression and appearance self-esteem. J Psychosom Res 72(3):199–204. doi:10.1016/j.jpsychores.2011.12.005 PubMedCrossRef

56.

Malcarne VL, Hansdottir I, Greenbergs HL, Clements PJ, Weisman MH (1999) Appearance self-esteem in systemic sclerosis. Cogn Ther Res 23(2):197–208CrossRef

57.

Antonowsky A (1993) The structure and properties of the sense of coherence scale. Soc Sci Med 36:725–733CrossRef

58.

Buck U, Poole J, Mendelson C (2010) Factors related to self-efficacy in persons with scleroderma. Musculoskelet Care 8(4):197–203. doi:10.1002/msc.181 CrossRef

59.

McFarlane AC, Brooks PM (1988) Determinants of disability in rheumatoid arthritis. Br J Rheumatol 27:7–14PubMedCrossRef

60.

Katz PP, Yelin EH (1993) Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis. J Rheumatol 20:790–796PubMed

61.

Wright GE, Parker JC, Smarr KL, Schoenfeld-Smith K, Buckelew SP, Slaughter JR, Johnson JC, Hewett JE (1996) Risk factors for depression in rheumatoid arthritis. Arthritis Care Res 9:264–272PubMedCrossRef

62.

Danieli E, Airo P, Bettoni L, Cinquini M, Antonioli CM, Cavazzana I, Franceschini F, Cattaneo R (2005) Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 24(1):48–54PubMedCrossRef

63.

Müller H, Rehberger P, Günther C, Schmitt J (2012) Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma. Br J Dermatol 166(2):343–353PubMedCrossRef

64.

Medsger TA (2003) Natural history of systemic sclerosis and the assesment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am 29:255–273PubMedCrossRef

65.

66.

Hamilton M (1969) Diagnosis and rating of anxiety. Br J Psychiatry 3:76–79 (Special publication)

67.

Zung WWK (1971) A rating instrument for anxiety disorders. Psychosomatics 12:371–379PubMedCrossRef

68.

Nguyen C, Bérezné A, Baubet T, Mestre-Stanislas C, Rannou F, Papelard A, Morell-Dubois S, Revel M, Guillevin L, Poiraudeau S, Mouthon L, Groupe Français de Recherche sur la Sclérodermie (2011) Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PLoS One 6(3):e17551PubMedCentralPubMedCrossRef

69.

Bérezné A, Seror R, Morell-Dubois S, de Menthon M, Fois E, Dzeing-Ella A, Nguyen C, Hachulla E, Guillevin L, Poiraudeau S, Mouthon L (2011) Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res (Hoboken) 63(2):277–285. doi:10.1002/acr.20342 CrossRef

70.

van Lankveld WG, Vonk MC, Teunissen H, van den Hoogen FH (2007) Appearance self-esteem in systemic sclerosis—subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables. Rheumatology (Oxford) 46(5):872–876CrossRef

71.

Caine TM, Foulds GA, Hope K (1967) Manual of the Hostility and Direction of Hostility Questionnaire. University of London Press, London

Titel: Negative affect in systemic sclerosis
verfasst von: Leticia Leon
Lydia Abasolo
Marta Redondo
Miguel Angel Perez-Nieto
Luis Rodriguez-Rodriguez
Maria Isabel Casado
Rafael Curbelo
Juan Ángel Jover
Publikationsdatum: 01.05.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 5/2014
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-013-2852-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2014

Prevalence of rheumatoid arthritis in Serbia

Elevated serum level of growth arrest-specific protein 6 (Gas6) in systemic lupus erythematosus patients is associated with nephritis and cutaneous vasculitis

The in vitro treatment with vitamin D3 is ineffective on the expression of PKC isoenzymes, but decreases further the impaired production of IL-2 in the T lymphocytes of SLE patients

Multiple endovascular stent-graft implantations in a patient with aortic thoracic and abdominal aneurysms due Takayasu arteritis

Distribution of HLA-DRβ1 alleles among well-characterized rheumatoid arthritis patients from Western India